About Rusan Pharma Limited
We are a technology driven Pharmaceutical Company managed by a team of professional technocrats. We specialize in the area of critical pain management, substitution treatment, opioid de-addiction, anti- tuberculosis, psychiatric drugs and anti-infectives.
Our business spectrum includes:
Pharmaceutical Research & Development
Manufacturing and Marketing of Formulations
Synthesis of niche APIs
Synthesis of Drug Intermediates
Providing contract research and analytical services to our partners
Preventing HIV by providing substitution treatment to opioid dependents and injecting drug users
We started our operations in 1994 by manufacturing commercial scale Buprenorphine Hydrochloride. The Indian Process Patent for Buprenorphine Hydrochloride rests with our Chairman, Dr. Navin Saxena. Our facilities include an ultra modern formulations unit approved by UK MHRA, South Africa MCC, Zimbabwe MCAZ, WHO-GMP and Sudan MOH.
We market our products in Europe, Newzeland, Australia, South Africa, Russia, Middle East, The CIS, South East Asia and The African countries through our own independent offices, distributors and marketing joint ventures.
Some of our products are leaders in their respective therapeutic categories in The CIS and have established themselves as household names.
We have obtained the Certificate of Suitability (COS) for Buprenorphine Hydrochloride Base from The European Directorate of Quality Medicine (EDQM) and approvals for other products like Methodone Hydrochloride, Fentanyl Citrate, Bisoprolol Fumarate and Tramadol are under way.
We give utmost importance to the quality management activities. In our unit no product is allowed to move out of the firm until and unless all the quality tests are completed. The products are tested by our team of quality controllers and production supervisors. They ensure that products are tested for features like purity, effectiveness, shelf life and toxicity.
Because of our consistent endeavors for quality management, we have obtained the Certificate of Suitability (COS) for Buprenorphine Hydrochloride Base from The European Directorate of Quality Medicine (EDQM). Approvals for other products like Methodone Hydrochloride, Fentanyl Citrate, Bisoprolol Fumarate and Tramadol are also underway.
Research & Development
As a technology driven enterprise and backed by technocrats as its pillars , Rusan has laid great emphasis on the research & development aspect since its inception. Rusan understands the criticality of developing new products to be ahead of the competition and providing better efficacy drugs at an affordable price to the masses. Rusan’s stress on computer aided drug design; novel drug delivery system; stereo selective catalytic reactions, nano particles technology; bio technology as the areas of future research sets the stage for a state-of-the-art R&D centre to be built in kandla , Gujarat in the near future. The R&D centre will be one of it's kind and shall house some of the best brains in the business to come out with innovative products to cater to the needs of the future.
Clients / Customers
Joint Ventures & Strategic Alliances
Rusan Pharma Ltd. is one of the leading exporters of medicines to the CIS Market, UK, and South Africa. The company also has a strong presence across Europe, Asia Pacific, Middle East, Syria, Ethiopia, Sudan, Egypt, Bangladesh, UAE, and Latin America.
Rusan Pharma Ltd.. has offices in Moscow, Kiev, Tashkent, India and Sharjah.
Our Management Team
Our Company is managed by the Board of Directors and the Corporate Team.
Meet our Board of Directors
The Board forms the backbone of our company and are responsible for our corporate governance and ultimately accountable for our activities, strategy and performance.
Meet our Corporate Team
The Chief Executive Officer (CEO) is responsible for the management of the business and is assisted by the Corporate Team that manages our activities. Each member is responsible for a specific part of the business.
Clients & Associates
- Alembic - India
- Arrow - Global
- AOP Orphan - Austria
- Akrikhin - Russia
- Arrow - New Zealand
- Baragshun - Mogolia
- City Med - South Africa
- Compware - Germany
- Dori Darmon - Uzbekistan
- Dr. Reddy’s lab - India
- Endocrine - Russia
- Equity - South Africa
- Farmalider - Spain
- Gold Shield - UK
- Genesis - UK
- Glenmark - India
- Jiri Horna - Czech
- L Pharma - Kazakhstan
- Molteni - Italy
- Midas - Germany
- Novartis - India
- Ranbaxy - India
- Reckitt Benckiser - UK
- Stada - Global
- Script Pharma - Australia
- Script - South Africa
- Worth Pharma - UK
- Vivatis - Germany
- Zydus Cadila – India
- Citi Medical - South Africa
- Gen Care - UK
- Quantis - Germany
As a responsible company, Rusan Pharma Ltd. strives to operate in a way that reflects our values, culture, and respect for our customers. We at Rusan are dedicated to creating a wide range of ideas, products and services that improve health and well-being of the public. Our responsibilities and potential impact, branches out far beyond the medicines we sell. For example, treating drug addicts by supporting non-government organizations (NGOs), we can help them to live accountable drug-free lives. To be responsible and accountable - socially, ethically and environmentally - is to be trusted. We need that trust to serve the society and support a sustainable enterprise. Protecting the Environment A healthy planet and a healthy community go hand in hand. We are increasing our efforts on environmental sustainability by finding better, eco-friendly catalysts. We need to optimise efficiency and increase our use of renewable materials and energy. Judicious use of clean water is also our top priority. Our People Rusan recognizes that differences in age, race, gender, nationality, physical ability, thinking style and background bring richness to our work environment. Part of our responsibility is to take care of the health and mental well-being of all our employees. We provide support programs and services to help our employees live healthier and safer lives – at work, home and on the road. Our feedback services extend not just for our customers but also for our employees who have a direct and confidential means of communicating with our chairman. Today’s youth will be tomorrow’s leaders. Rusan realizes this and plans to invest in a brighter future. Offering internship and scholarship opportunities to talented young students is part of Rusan’s responsibility. This will not only help us attract the best and the brightest talent, but also give graduates a chance to get valuable work-experience and training. Work ethics At Rusan we are committed to creating a strong ethical work culture. Profit without principle is short lived therefore putting patients first is the core principle of being an ethical pharmaceutical company. We try to instil in all our employees ethical values such as:
- Transparent work culture
|Rusan embraces a challenging & inspiring mission which is to :|
|“Improve the health and quality of human life.”|
|This mission empowers each employee to help millions of people around the world. Rusan expects returns, but only from work that satisfies the healthcare professional and patient needs.|
Rusan firmly believes that access to quality healthcare is a right, not a privilege. We will endeavour to ensure the availability of world class, quality medicines at affordable prices, across the globe and are committed to work toward a healthier & happier world.
|Our experience and expertise in the field of pain management & addiction treatment has already helped us to address these growing health problems by providing medicines of high efficacy by using better drug delivery systems & innovative services.|
|When I first started the company, I had the privilege of working closely with talented and committed people across all levels of our organisation. I have seen Rusan grow from just a few people with lots of ideas, fantastic imagination and above all a thirst to become a global player in our business. Over the years, I have realised that our human resources will continue to be the most valuable asset in this pursuit of leadership & the prime driving force for our growth.|
Today Rusan is at a very interesting point in its evolution, well on course on its intended journey to emerge as a global generics powerhouse – a point in time where I find not only a new level of energy and excitement brewing within, but most importantly a keen sense of pointed urgency to achieve and excel.
|At Rusan we believe that success is often achieved through close collaboration with partners who share a common vision and possess complementary strengths. Fortunately, Rusan is blessed with a number of good trustworthy partners and I am confident that with this new synergy Rusan will be able to fulfil its mission.|
|Rusan aspires to provide customer satisfaction and be leader in all its markets across the globe. With a world class research and development team, we are confident in providing high-quality products & services.|
|Since its inception my prime focus has always been on high growth emerging markets, which have shown double digit growth momentum in their economies. I have made sure that Rusan has a strong presence in many countries, for example Russia, South Africa, India, China and Brazil. Backed by a strong economy and growing middle class purchasing power, I believe that Rusan is well poised to capitalise on the growing generic opportunities.|
|With the ever changing industry trends, I believe that Rusan is ready to take on fresh challenges by embracing original technologies, novel drug delivery systems, stereo-selective & bio-catalysts.|
Our vision is to be a worldwide leading pharmaceutical company & to become a significant global player by providing high quality, affordable & innovative solutions in medicine & treatment.
Rusan’s core foundation is based on the following values:
|Following these firm values, Rusan aims to be amongst the most admired pharmaceutical company both in India & abroad, by the turn of this decade.|
Products Pipeline APIs Under Development :-
- Oxycodone HCI USP
- Dihydrocodeine tartrate BP/ USP
- Oxymorphone HCL USP
- Hydrocodone HCL UPS
- Hydromorphone HCL USP
- Detomidine HCL ph.Eur
- Perindopril Erbumine Ph.Eur
- Opiate Prodrugs
- Clopidogrel Hydrogen Sulphate Form 1 & 2
- Cetirizine Di-Hydrochloride
- Es-Omeprazole Magnesium
- Enalapril Maleate
- Itraconazole (Mesylate, Tosylate & Pharma)
- Losartan Potassium
- Pantaprazole Sodium Sesqui Hydrate
- Phenyl Ephrine Hydrochloride
- Sertraline Hydrochloride
- S-Citalopram Oxalate
- Salbutamol Sulphate
- Sotalol Hydrochloride
- Tramadol Hydrochloride
- Pioglitazone Hydrochloride
To,Rusan Pharma Limited